ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations

Liu, Wenxin*; Jiang, Qiuying; Sun, Chao; Liu, ShiHao; Zhao, Zhikun; Wu, Dongfang哈尔滨医科大学; 河北医科大学; 1
BMC CANCER2022-2-21DOI: 10.1186/s12885-022-09291-z
2被引10阅读
引用收藏
分享

摘要

Background Cervical cancer is frequently detected gynecological cancer all over the world. This study was designed to develop a prognostic signature for an effective prediction of cervical cancer prognosis. Methods Differentially expressed genes (DEGs) were identified based on copy number variation (CNV) data and expression profiles from different databases. A prognostic model was constructed and further optimized by stepwise Akaike information criterion (stepAIC). The model was then evaluated in three groups (training group, test group and validation group). Functional analysis and immune analysis were used to assess the difference between high-risk and low-risk groups. Results The study developed a 5-gene prognostic model that could accurately classify cervical cancer samples into high-risk and low-risk groups with distinctly different prognosis. Low-risk group exhibited more favorable prognosis and higher immune infiltration than high-risk group. Both univariate and multivariate Cox regression analysis showed that the risk score was an independent risk factor for cervical cancer. Conclusions The 5-gene prognostic signature could serve as a predictor for identifying high-risk cervical cancer patients, and provided potential direction for studying the mechanism or drug targets of cervical cancer. The integrated analysis of CNV and mRNA expanded a new perspective for exploring prognostic signatures in cervical cancer.

学科与关键词

关键词
Cervical cancerCopy number variationsDifferential expressed genesPrognostic signatureBioinformatics
相关
加载中…
  • Identification and verification of a 4-gene signature predicting the overall survival of cervical cancer
    Yuan, Lu; Lu, Zijun; Sun, Guoqiang*; Cao, Dongmei*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2022, 101(42): e31299.
  • A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer
    Chen, Hongxia; Li, Hongying*; Wang, Lei*; Li, Yaxiong; Yang, ChunYanJOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42(2): 327-332.被引 3
  • Identification and Validation a Necroptosis-Related Prognostic Signature in Cervical Cancer
    Yang, Zerui; Li, Junren; Tang, Yubo; Zou, Lili*Reproductive Sciences, 2023, 30(6): 2003-2015.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
BMC CANCER
发表日期
2022-02-21
卷期
第 22 卷, 第 1 期
页码
192
DOI
10.1186/s12885-022-09291-z
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of Tianjin, China [20JCZXJC00100]

作者

  • L

    Liu, Wenxin (通讯) (第一作者)

  • J

    Jiang, Qiuying

    2 · harbin med univ

查看全部 6 位作者收起作者
  • S

    Sun, Chao

    1

  • L

    Liu, ShiHao

    hebei med univ

  • Z

    Zhao, Zhikun

    1

  • W

    Wu, Dongfang

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417